Philip Morris
Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
Fields
- Author
- Pomerleau, C.S.
- Pomerleau, O.F.
- Tate, J.C.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Middle Tn State Univ
- Natl Inst on Drug Abuse
- NCI, Natl Cancer Inst
- Named Person
- Green, S.B.
- Lutzke, M.
- Tate, J.C.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Addiction
- Univ of Mi
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Addiction (1994) 89, 321-330
Pharmacological and non-pharmacological
smoking motives: a replication and extension
JAMES C. TATE, CYNTHIA S. POMERLEAU &
OVIDE F. POMERLEAU
University of Michigan Behavioral Medicine Program, Ann Arbor, Michigan, USA
Abstract
Cigarette smokers (n = 387) completed a questionnaire measure of smoking motives, and subgroups of
this
sample provided external validation information. Seven factors emerged from a primuipal components'
analysis: automatic, sedative, addictive, stimulation, psychosocial, indulgent and sensorimotor
manipulation.
A higher-order principal components analysis revealed the presence of two second-order factors.
Inspection of
the pattern of correlations between factor scores and criterion variables clearly indicated that the
first four
factors above and their underlying second-order factor are more closely related to nicotine
pharmacology and
mood-altering effects of nicotine than the latter three motives and their underlying second-order
factor.
Moreover, the positive correlations between these pharmacological motives and age, coupled with a
negative
relationship between age and the non-pharmacological motives, support the description of the smoking
career
as a progressive transfer of reward from non-pharmacological to pharmacological factors. These
findings
suggest that self-reported reasons for smoking represent more than bias in verbal report.
Introduction
The question, "why do people smoke?" concisely
summarizes the thrust of a large portion of
cigarette smoking research conducted over the
last three decades. A direct approach to answer-
ing this question is to ask smokers their reasons
for smoking. Beginning in the mid-1960s, re-
searchers began constructing questionnaires
designed for this purpose and analyzing re-
sponses to these questionnaires to detect
evidence of smoking motives. The development
of reliable, valid self-report measures of smok-
ing motives is important for both basic and ap-
plied reasons. Smoking motive scales would
allow measurement of private events mediated by
the proposed neuro-regulatory effects of nicotine
Correspondence to: Chris Tate, Ph.D., PO Box 87, Depart-
ment of PsycholoQy, Middle Tennessee State University,
Murfreesboro, TN 37132, USA.
1
(Pomerleau & Pomerleau, 1984). Relating smok-
ing motive scores to external criterion variables
would help to separate pharmacological and
non-pharmacological factors in cigarette smok-
ing and further our understanding of smoking.
Moreover, the identification of specific smoking
motives could guide the tailoring of smoking
cessation treatment to the individual needs of
patients (Kreitler, Shahar & Kreitler, 1976).
Smoking motive questionnaires have been
based on affect management models (Ikard,
Green & Horn, 1969), situations associated with
smoking (McKennell, 1970; Best & Hakstian,
1978) and arousal modulation models (Frith,
1971). Because the questionnaires used in these
studies were not identical, different sets of smok-
ing motives were found. Nevertheless, the large
degree of content overlap resulted in the finding
of similar sets of smoking motives, and the re-
sults of factor analytic studies demonstrate
excellent consistency (Tate, Schmitz & Stanton,
321

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
.!'
322 James C. Tate, Cynthia S. Pomerleau & Ovide F. Pomerleau
1991). Different researchers labeled motives dif-
ferently, but the following are representative
names of the most commonly found motives:
automatic (ATM), sedative (SED), addictive
(ADD), stimulation (STM), psychosocial
(SOC), indulgent (IND) and sensorimotor ma-
nipulation (SMM).
Russell, Peto & Patel (1974) approached
the question of smoking motives from the
perspective of pharmacological versus
non-pharmacological rewards of smoking. Using
a 34-item questionnaire derived from both the
Ikard et al. (1969) and McKennell & Thomas
(1970) measures, Russell et al. (1974) recovered
six of the seven smoking motives (ATM, ADD,
STM, SOC, IND & SMM) and found evidence,
via a higher-order factor analysis, of two more
basic dimensions underlying these smoking mo-
tives. The first dimension, described as
representing the pharmacological rewards of nic-
otine, was composed of the ATM, ADD and
STM smoking motives. Although the expected
SED factor did not emerge, these investigators
suggest that it should lbad on the pharmaco-
logical dimension. The second, non-
pharmacological dimension was composed of
the SOC, IND and SMM smoking motives.
Russell et al. (1974) speculated that social and
other non-pharmacological rewards motivate
smoking initially and account for the stronger
role of the SOC, IND and SMM motives early in
the smoker's career. Eventually, the positive re-
wards of nicotine, due to its direct and indirect
actions on the brain, exert more control as the
smoker increasingly uses nicotine to modulate
arousal and affective tone, thus accounting for
the stronger role of the SED and STM motives
as the smoker's career progresses. As nicotine
intake increases and the pattern of intake be-
comes more regular, avoidance and relief of
withdrawal become paramount, and the ATM
and ADD motives becomes stronger. Thus,
smokers progress along two orthogonal dimen-
sions as they continue to smoke. Initially,
non-pharmacological rewards exert greater con-
trol over smoking; however, pharmacological
rewards develop greater control.
The validity of the pharmacological dimension
was supported by moderate positive correlations
(i.e., r= 0.50-0.63) between STM, ADD, ATM
and SED motive scores and smoking rate. Also,
this dimension discriminated between a sample
of normal smokers not attempting to quit and a
sample of addicted heavy smokers attending
smoking cessation clinics. Specifically, clinic
smokers scored higher on the pharmacological
smoking motives. The non-pharmacological mo-
tives did not correlate as highly with smoking
rate, and the SOC motive correlated negatively
with age as predicted (Russell et al., 1974). Addi-
tional validation comes from three subsequent
studies (Niaura et al., 1989; West, Hajek &
Belcher, 1986; West & Russell, 1985) that
demonstrated predicted relationships between
pharmacological smoking motive scores and vari-
ous criterion variables (i.e., withdrawal
symptomatology, smoking rate, expired carbon
monoxide, cotinine levels, etc.).
These studies lend support to the validity of
Russell et al.'s (1974) pharmacological and non-
pharmacological dimensions, but there are
limitations. Limited sample sizes (n = 29-77)
limit the reliability of the findings. Indeed, the
correlation between ATM scores and smoking
rate is the only consistent finding across the
studies. Also, some results contrary to Russell et
al.'s model emerged. Russell et al. (1974), West
& Russell (1985), and West et al. (1986) found
that IND motive scores behaved more like those
belonging to the pharmacological group (i.e.,
correlated positively with criterion variables).
Similarly, Niaura et al. (1989) found significant
positive correlations between IND and SMM
scores and withdrawal and urge to smoke scores.
Finally, in Russell et al. (1974), the ratio of
subjects to questionnaire items used in making
factor estimations (i.e., 5 to 1) is close to the
minimum rule of thumb guide of 4 to 1(Kim &
Mueller, 1978). It is possible that this fact ex-
plains the failure to obtain an SED factor. Given
that the stability of a factor solution increases as
this ratio increases, replication in a large sample
would increase confidence in this model of
smoking behavior.
The general goal of this study was to examine
the relationships between self-reports of smoking
motives and external validation criteria in an
attempt to establish the pharmacological under- ~
pinnings of specific reasons for smoking. As a~
first step towards demonstrating this, the follow- ~
ing sub-goals were set and specific predictions ~
made. First, we attempted to recover the first-or- ~
der and second-order factor structures described ~
by Russell et al. (1974). Secondly, to establish ~
the pharmacological and non-pharmacological t\L
natures of these factors, we investigated the rela- C_~

I
I
I
I
I
I
Pharmacological and non-pharmacological smoking motives 323
tionships between smoking motive scores and an
array of pharmacological marker variables. We
predicted that the ATM, SED, ADD, STM and
the underlying second-order factor would corre-
late positively with plasma cotinine, smoking
rate, length of time smoking, age and a question-
naire measure of nicotine dependence and
negatively with latency to the first cigarette of the
day. Also, we predicted that the SOC, IND,
SMM and their underlying second-order factor
would correlate negatively with age and mini-
mally, mally, or not at all, with the criterion measures.
s Thirdly, we predicted that a sub-sample of sub-
jects recruited to participate in smoking cessation
I trials would have higher scores on the pharmaco-
logical motives and lower scores on the
non-pharmacological motives as compared to a
r sub-sample of regular smokers not attempting
~ smoking cessation. Finally, we predicted positive
relationships between pharmacological motive
scores and measures of trait anxiety and de-
pression. It was reasoned that individuals
~ reporting higher levels of subjective distress due
to personality make up, negative environmental
events or nicotine withdrawal would be more
likely to report stronger pharmacological reasons
~ for smoking.
I Method
Sub~'ects
Subjects were 387 cigarette smokers (179 fe-
males, 208 males) who participated in research
~ projects carried out at the University of Michi-
gan's Behavioral Medicine Program between
1986-1993. Two hundred and fifty-three of
these subjects (106 females, 147 males) partici-
pated pated in laboratory projects, and 134 (73
~+ females, 61 males) were participants in clinical
trials involving smoking cessation. Laboratory
~ subjects were chosen to be healthy, moderately
dependent smokers and may not be representa-
tive of all smokers. Inclusion criteria for clinic
subjects were somewhat less restrictive and
~ specifically included a current desire to quit
smoking.
I
Measures
Measures completed by most subjects included a
smoking history form, the Fagerstrom Tolerance
Lushene, 1970) and depression (CES-D; Weiss-
man et al., 1977) measures, and a modified
version of the Russell et al. (1974) smoking
motives questionnaire (SMQ; Pomerleau et al.,
1992). The modified SMQ was constructed by
examining the factor structure reported in Rus-
sell et al. (1974) and, for each factor, selecting
the three items with the highest significant (i.e.,
_- 0.40) loadings in conjunction with non-
significant loadings on the other factors. Only
two such items could be found for the ATM and
SED motives; consequently, a third item was
rationally constructed for each of these scales.
Appendix A contains the resulting scales. Re-
sponses to items are made on a 0 (not at all) to
3 (very much so) scale. Additionally, 297 sub-
jects supplied plasma samples which were
assayed for cotinine concentration via either
high-pressure liquid chromatography (Hariha-
ran, Van Noord & Greden, 1988) or gas
chromatography (Jacob, Wilson & Benowitz,
1981). Due to changes in study demands and
missing data, criterion variables data were in
some instances available for only subsets of the
database.
Procedure
Questionnaire materials were provided at a
screening session and subjects completed these
prior to actual involvement in a study. Data were
inspected for completeness and entered into the
database. Plasma samples were obtained prior to
any experimental manipulations or provision of
treatment. In some cases, these samples were
collected after overnight smoking abstinence.
Results
Subjects
Table 1 shows descriptive data on the total sam-
ple, by sex, and laboratory/clinic subgroups.
Generally, subjects were young, moderate smok-
ers who reported smoking for an average of 16
years and being moderately dependent on
nicotine. Univariate analyses of variance
(ANOVA) testing for sex differences on these
variables were non-significant with the exception
of plasma cotinine concentration [F(l,
295) = 5.20, p = 0.023] with males having the
higher concentration. Clinic and laboratory sam-
ples differed significantly on age [F(l,
385) = 236.87], years smoked [F (1,
~ Questionnaire (FTQ; Fagerstrom, 1978), trait
anxiety (STAI-Trait; Spielberger, Gorsuch &
I
~w

I
I
I
I
I
i
I
I
I
I
I
I
I
I
I
I
1
I
I
-0
324
,3`ames C. Tate, Cynthia S. Pomerleau & Ovide F. Pomerleau
Table 1. Subject characurran'ss
Variable Males Females Lab. Clinic Total
Age (yrs)
Mean
32.84
32.80
28.86
40.31
32.82
SD (9.10) (8.88) (6.38) (7.95) (8.84)
n 208 179 253 134 387
Plasma cotinine (ng/ml)
Mean
281.67
250.12
240.95
306.92
268.71
SD (124.22) (106.56) (120.25) (104.05) (118.13)
n 175 122 172 125 297
Smoking rate (cigs/day)
Mean
27.48
25.83
23.55
32.54
26.71
SD (11.99) (8.38) (7.57) (12.44) (10.47)
n 203 179 248 134 382
Years smoked
Mean
16.65
17.16
13.00
22.99
16.88
SD (9.06) (8.32) (6.71) (8.02) (8.72)
n 189 154 210 133 343
FTQ
Mean
7.23
7.32
6.88
7.76
7.27
SD (1.69) (1.74) (1.80) (1.44). (1.71)
n 165 158 244 99 323
Latency* (min)
Mean
24.04
28.48
25.80
SD 31.85 27.35 30.84
n 73 48 121
* Data available for laboratory subjects only.
341) = 151.67], smoking rate
267) = 76.92], plasma cotinine
295) = 24.36], and FTQ [F(l, 321) =
[F(l,
[F(1,
18.31]
(all p= 0.0001). Clinic subjects had higher val-
ues on all of these variables.
Factor analysds
First-order analysis. Responses to the 21 SMQ
items were entered into a principal components
analysis. Using Kaiser's (1974) criterion (eigen-
values ;~, 1) to determine how many factors to
retain, a clear seven-factor solution, accounting
for 65% of the total variance, emerged. The
seven factors each accounted for 23, 10, 9, 7, 6,
5 and 5% of the total variance, respectively.
Following factor extraction, initial rotation was
achieved via the varimax method, and rotation to
a terminal solution was achieved via the oblique
promaz method.
Table 2 shows the factor loadings greater than
0.40 after rotation, communalities (It2), and
Kaiser's Measure of Sampling Adequacy (MSA;
Kaiser, 1970, 1974). Comparison of Table 2 and
Appendix A indicates that items loaded mainly
on only one factor and the predicted pattern of
factor loadings was obtained. Only six of 147
factor loadings were contrary to predictions to a
significant degree. Two factors (ATM, IND)
emerged exactly as predicted, and the SED and
SMM factors emerged with an additional item
loading significantly on each. For each of the
SOC, ADD and STM scales, two of the three
items behaved as predicted.
Kaiser's (1970, 1974) MSAs were calculated
for each item and overall. This statistic is a
measure of the degree to which the variance in
each variable is accounted for by common fac-
tors, that is, the level of factorial determination
(Kim & Mueller, 1978). The MSA can vary
between 0 and 1, with higher values indicating
greater factorial determination and empirical
confirmation of a given factor solution. The last
column of Table 2 contains MSAs for individual
items. The overall MSA is 0.77. Using Kaiser's
guidelines for interpretation, these values are
quite acceptable and support the appropriateness
of the seven-factor solution.
Second-order anaFysis. Inspection of the corre-
lation matrix in Table 3 reveals moderate
inter-correlations among the seven factors with

I
i
I
Pharmacological and non-pharmacological smoking motives 325
I Table 2. Factor loadings* from first-order factor analysir
Factor
I Item ATM SED SOC IND ADD SMM STM h2 MSA
3 0.91 0.81 0.67
1 0.84 0.71 0.75
2 0.78 0.64 0.81
4 0.76 0.61 0.84
I 6 0.69
5 0.69 0.64 0.83
0.64 0.84
9 0.67t - 0.46t 0.64 0.81
8 0.81 0.70 0.75
~
7 0.81 0.76 0.77
,~
20 0.54j- 0.44t 0.55 0.87
11 0.84 0.70 0.61
10 0.84 0.70 0.60
12 0.53 0.46 0.73
I 15 0.77 0.63 0.77
13 0.74 0.65 0.84
16 0.84 0.71 0.66
14 0.53 0.59 0.82
~ 17 0.52t 0.57 0.63
18 0.40t 0.44 0.58 0.67
19 0.87 0.74 0.71
21 0.68 0.66 0.80
I * Standardized regression coefficients. Loadings < 0.40 not shown. t Loadings contrary to pre-
dictions.
1coefficients ranging from - 0.05 to 0.37.
Consequently, the seven factors were arranged
uch that more highly correlated factors are ad-
acent, forming two groups of intercorrelated
iii~~~ctors. This prompted a second-order principal
components analysis. Two second-order factors,
I espectively accounting for 28% and 18% of the
otal variance, emerged using Kaiser's criterion
to terminate factor extraction. Rotation to simple
structure was achieved initially via the varimax
tethod and terminally via the promax method.
able 4 contains the seven first-order factors and
their loadings on the two second-order factors.
The two second-order factors demonstrated a
~ow inter-correlation (r = 0.15).
'..
alidiry
I'able 5 contains correlations between factor
scores and criterion variables. Five of these vari-
ables relate directly to cigarette consumption,
cotine intake and nicotine dependence (plasma
otinine, smoking rate, years sinoked, FTQ, la-
tency to the fust cigarette of the day). Age was
because Russell et al. (1974) postulated
Icluded positive relationship between age and strength
of the pharmacological rewards of smoking and a
negative relationship between age and the
strength of the non-pharmacological rewards of
smoldng. Due to the large number of correla-
tions, minimum significance was set at pt!G 0.01.
Factor I, ATM and ADD scores correlated as
predicted with all criterion variables. The STM
scores correlated as predicted with four of six
criterion variables, and SED scores correlated
with number of years smoking. With the excep-
tion of a significant positive correlation between
SOC scores and smoking rate, none of the corre-
lations involving the SOC, IND, SMM and
Factor II scores were significant. There was,
however, a trend (p < 0.05) for IlVD and Factor
II scores to correlate negatively with age. Focus-
ing only on the correlations between
second-order factor scores and criterion vari-
ables, Student's t-statistic was computed to test
whether differences between correlation
coefficients are significant. In every case, the
difference was significant. Correlations between
Factor I and pharmacological marker variables
are significantly larger than comparable correla-
tions involving Factor II.
Next, motive factor scores for the clinic and

I
I
I
i
I
I
I
1
I
I
I
I
I
I
I
I
I
I
326
,fames C. Tate, Cynthia S. Pomerleau f7 Ovide F. Pomerleau
Table 3. Inter-facror correlations
ATM SED ADD STM SOC IND SMM
ATM 1.00
SED 0.25 1.00
ADD 0.25 0.37 1.00
STM 0.23 0.14 0.23 1.00
SOC 0.19 0.24 0.07 0.20 1.00
IIZD 0.00 - 0.05 0.00 - 0.02 0.22 1.00
SMM 0.25 0.07 0.05 0.08 0.20 0.07 1.00
laboratory sub-samples were compared using
univariate ANOVAs. Significant results were ob-
tained for the STM [F(1, 385) = 27.81,
p= 0.0001), ADD [F(i, 385) = 88.62,
p= 0.0001], SED [F(1, 385) = 25.09,
p= 0.0001], IND [F(1, 385) = 7.08, p= 0.008)
and SMM [F(1, 385) = 4.04, p= 0.045] mo-
tives. Clinic subjects had higher STM, ADD,
SED and IlVD scores and lower SMM scores
than the laboratory sub-sample. This analysis
was repeated with the second-order factor scores
as dependent variables, and similar results were
obtained. Clinic subjects had higher Factor I
scores [F(1, 385) = 73.49, p= 0.0001]. The
ANOVA involving Factor II scores was non-
significant [F(1, 385) = 0.06, p= 0.81].
To assess further the validity of the smoking
motive factors, factor scores were correlated with
measures of trait anxiety and depression (see
Table 6). The SED, ADD, Factor I scores corre-
lated significantly with STAI scores. The SED
scores correlated with CES-D scores also. Con-
trary to predictions, SOC scores correlated
significantly with STAI scores.
Table 4. Fauor loadi'ngs* frons tlu second-
order factor analysu
Second-order factors
First-order
factors
Factor I
Factor II
ADD 0.73 - 0.15
SED 0.70 - 0.02
ATM 0.61 0.13
STM 0.53 0.10 '
SOC 0.23 0.71
IND - 0.25 0.69
SMM 0.09 0.58
* Standardized regression coefficients.
Discussion
The goal of this study, to exam±ne smoking
motives systematically in a larger population,
were largely met. The findings replicate and
extend the results of previous investigations of
self-reported smoking motives and their relation-
ships to nicotine pharmacology. Seven smoking
motives were identified by factor analysis, and a
second-order factor analysis revealed the pres-
ence of two more basic dimensions. These first-
and second-order factors are strikingly similar to
those obtained by Russell et al. (1974) in terms
of item composition, inter-factor correlations
and variance accounted for. However, we found
a much clearer separation between the second-
order factors as evidenced by the unequivocal
pattern of second-order factor loadings and the
low inter-factor correlation. In addition, pre-
dicted relationships between smoking motive
factor scores and external criterion variables
were observed.
Correlations between most of these dimen-
sions and pharmacological markers
demonstrated predicted patterns, thus lending
credence to the pharmacologicai and non-phar-
macological labels applied by Russell et al.
(1974). Factor I clearly seems more pharmaco-
logical in nature than Factor II. Furthermore,
STM, SMM, ADD, SED and Factor I scores
discriminated between a group of heavy, ad-
dicted smokers seeking smoking cessation
treatment and a group of less'dependent smok-
ers. Lastly, subjects with higher SED scores
reported being generally more anxious and de-
pressed, subjects with higher ADD scores
reported being more anxious, and subjects with
higher Factor I scores reported being more anx-
ious. These results imply that smokers who
experience more subjective distress may derive
greater reinforcement and/or relief of dysphoric
states from smoking.
I

I
I
I
Pharmacological and non-pharmacological smoking motives 327
I Table 5. Correlation.s between factor scores and criterion variables
Factor Plasma
cotinine
(n = 297) Smoking Years
rate smoked Age FTQ Latency
(n = 382) (n = 343) (n = 387) (n = 323) (n = 121)
I ATM 0.24*** 0.48*** 0.33*** 0.29*** 0.27*** - 0.28*
SED - 0.03 0.09 0.14* 0.07 0.12 - 0.10
ADD 0.21** 0.39*** 0.34*** 0.32** 0.33*** - 0.28*
STM 0.11 0.28*** 0.25*** 0.24*** 0.16* - 0.02
~
~ Factorl 0.20** 0.47*** 0.40*** 0.35*** 0.33*** - 0.24*
SOC - 0.04 0.15* 0.01 - 0.01 0.14 - 0.10
IND -0.01 -0.08 -0.07 -0.11 0.10 -0.04
,~ SMM -0.10 0.12 -0.10 -0.09 -0.07 0.10
Factor II - 0,08 0.09 - 0.08 - 0.10 0.09 - 0.02
t 3.96** 6.43** 7.60** 7.33** 3.57** 3.99**
I
*p<0.01,**p<0.001,***p<0.0001.
Not all results were as predicted. Clinic sub-
6ects had higher IND scores than laboratory
~~~ubjects. Otherwise, IND scores behaved as
non-pharmacologically based. This motive,
originally postulated as straddling the pharma-
ological/non-pharmacological dimension, was
und by Russell et al. (1974) to load on a
non-pharmacological second-order factor and
o correlate significantly with daily smoking rate,
seemingly paradoxical finding. West et al.
1986) and West & Russell (1985) reported
significant positive correlations between II,1D
ores and pharmacological marker variables.
~
us, there is precedent for ambiguity concern-
g
g the IND smoking motive, and further
research will be needed to clarify the nature of
Ws motive.
Also, the non-pharmacological SOC motive
correlated with smoking rate and trait anxiety
t ores. It is possible that some anuous individu-
I
I
I
I
Table 6. Relationships between smoking motive
factor scores, trait anxaery and depression
Trait anxiety Depression
Factor (n = 372) (n = 200)
ATM 0.05 0.07
SED 0.16* 0.25**
ADD 0.14* 0.06
STM 0.03 - 0.07
Factor I 0.14* 0.13
SOC 0.16* 0.06
IND -0.09 -0.05
SM.M 0.09 - 0.03
Factor 11 0.07 - 0.005
*p<0.01,**p<0.001.
als score highly on the SOC motive because they
experience heightened anxiery when in social
situations, and the act of smoking may represent
a pharmacological coping device (Pomerleau &
Pomerleau, 1984). Two pieces of evidence sup-
port this interpretation. First, the two items
loading highest on the SOC factor (items 10, 14)
contain content suggesting increased ease and
confidence via smoking in social situations. This
is conceptually similar to the avoidance or re-
duction of negative affect central to the concept
of SED smoking. Secondly, the SOC and SED
motives are correlated significantly in this sample
(see Table 3). Although plausible, the present
correlational design cannot settle the issue.
Finally, the SED factor's showing was not as
consistent or as strong as expected. The SED
scores correlated as predicted with number of
years smoked, trait anxiety and depression;
demonstrated a marginal trend with respect to
FTQ scores and latency to the first cigarette of
the day; but were unrelated to plasma cotinine,
smokting rate and age. Russell et al. (1974) failed
to find evidence of an SED factor. As with the
IND factor, there is precedent for inconsistency,
and further research may shed light on the mat-
ter.
These findings have several implications. First,
individuals who report smoking to increase/de-
crease arousal or because of habit or addiction
are likely to be using nicotine for its pharmaco-
logical effects. Thus, the stimulatory and
sedative functions of smoking are probably medi-
ated by mcotine. Moreover, the automaticity of
smoking may serve to maintain nicotine levels
above a certain threshold, thus preventing with-
I

I
I
I
I
I
I
1
I
I
I
I
I
I
I
I
328 ,3`ames C. Tate, Cynthia S. Pomerleau & Ovide F. Pomerleau
drawal. When abstinence is unavoidable, dis-
comfort and craving motivate drug seeking.
Although the present study does not represent a
direct test of these assertions, the general finding
that the ATM, SED, ADD and STM smoking
motives are more strongly related to external
validation criteria than the SOC, IND and SMM
motives is consistent with the view of smoking
being motivated by both the mood-altering ef-
fects of nicotine and avoidance/relief of nicotine
withdrawal (Pomerleau & Pomerleau, 1984).
The positive correlations between SED and Fac-
tor I scores and mood and anxiety further
support this interpretation.
Secondly, positive correlations between phar-
macological factors and length of time smoking
and age support the description of the smoking
career as a progressive transfer of reward and
control from predominantly non-pharmacologi-
cal to predominantly pharmacological factors. A
longitudinal design would be needed to support
this interpretation unequivocally, but the current
data show small to moderate significant relation-
ships in predicted directions and are consistent
with the development of increasing tolerance
to nicotine as a function of years of smoking
described elsewhere (Henningfield &
Nemeth-Coslett, 1988). Stronger negative rela-
tionships between age and the non-
pharmacological factors might have been
obtained if younger smokers (age < 18 yrs) were
included in the sample. Russell et al. (1974)
recruited subjects as young as 16 years of age
and obtained a correlation between age and SOC
scores of - 0.23. More recent support for this
interpretation comes from a longitudinal study
by Stanton et al. (1993) in which reasons for
smoking were assessed in a cohort of children at
ages 11 and 13 years. They found that the im-
portance of "image" smoking ("I look better
with a cigarette in my hand") declined
significantly during the intervening two years,
and smoking because of "friends" ("I smoke
because I don't want to be the odd one out in a
group") demonstrated a statistically significant,
but small, degree of consistency. Possibly, the
rapidity with which people become nicotine de-
pendent renders psychosocial motives less
important in a similarly rapid fashion.
A review of the RFS (Tate et al., 1991) docu-
mented that groups of smokers report
remarkably similar motives with excellent con-
sistency; however, analogue, self-monitoring and
treatment studies support neither the validity nor
clinical utility of the individual motive scales.
Although the literature is fraught with methodo-
logical problems, this finding raises the issue of
the relationship between self-reported smoking
motives and actual smoking behavior. Schachter
(1978) argued that the "psychological and prob-
ably the sensory and manipulative gratifications
of smoking are illusory" (p. 112). Because the
RFS and SMQ share item content, this issue is
relevant to the SMQ. The results presented here
demonstrate clearly that some smoking motives
have stronger pharmacological ties than other
motives. Consequently, motive scores represent
more than self-report bias. Nevertheless, the
specific nature of these ties remains speculative.
Consequently, the answer to the question of
why people smoke continues to be elusive. A
partial reason for the difficulty may be that nic-
otine is a drug with multiple pharmacological
properties and that the tenacity of cigarette
smoking is based upon the diversity of nicotine's
actions (Pomerleau & Pomerleau, 1984). In view
of the apparent ability of smokers to secure a
wide range of effects, with reinforcement value
modulated by ongoing activities and environ-
mental context, a productive use of the findings
of motives-for-smoking research might be to pro-
vide guidance for systematic investigations
of the circumstances that trigger smoking and
the subjective, behavioral, physiological and
neuroendocrine consequences of nicotine self-
administration. Such research may resolve some
of the contradictions and ambiguities of the ini-
tial attempts to classify smokers and, ultimately,
should lead to a better understanding of nicotine
dependence and cigarette smoking.
Acknowledgements
Preparation of this manuscript was supported by
National Institute on Drug Abuse Grant DA
06529 and by National Cancer Institute Grant
CA 42730 to the third author. The authors are
grateful to Samuel B. Green and Mary Lutzke
for their valuable assistance. Correlation ma-
trices are available from the first author.
Z11:)
References ~
Bnsr, A. J. & HAxsnt+N, A. R. (1978) A situationC' ~
specific model for smoking behavior, Addica%.-,
Behaviors, 3, pp. 79-92. ©
I

i
I
I
Pharmacological and non-pha»nacological smoking motives 329
_ FAGERSTROM, K. O. (1978) Measuring degree of physi-
cal cal dependence to tobacco smoking with reference to
individualization of treatrnent, Addicrive Behaviours,
3, pp. 235-241.
~ FtuTti, C. D. (1971) Smoking behaviour and its rela-
tion to the smoker's immediate experience, British
Journal of Social and Clinical Psychology, 10, pp.
73-78.
i HARtHAN, M., VANNooRi), T. & GxEDEN, J. F. (1988)
~ A high-performance liquid-chromatographic method
for routine simultaneous determination of nicotine
and cotinine in plasma, Clinical Chemistry, 34, pp.
724-729.
~ HENNirrGFtEin, J. E. & NEMETH-Costfrr, R(1988)
Nicotine dependence: interface between tocacco and
tobacco-related disease, Chesr (Supplement), 93, pp.
37S-55S.
~ Ixnttn, F. F., GxEEN, D. E. & HoxN, D. (1969) A
~~ scale to differentiate between types of smoking as
related to the management of affect, Inurnational
Journal of the Addictions, 4, pp. 629-639.
~ JACOB, P., WILSON, M. & BENOwnz, N. L. (1981)
Improved gas chromatographic method for the de-
termination of nicotine and cotinine in biologic
fluids, Journal of Chromatography, 222, pp. 61-70.
KA1SEFt, H. F. (1970) A second-generation little jiffy,
Psychometrika, 35, pp. 401-415,,
~ KAtsEtt, H. F. (1974) An index of factorial simplicity,
~ Psychometrika, 39, pp. 31-36.
Ki.`s, J. & MvEU.Ett, C. W. (1978) Factor Analysis:
Statistical Met3wds and Practical Issues (Beverly Hills,
Sage).
KxErrt.ER, S., SHAxAR, A. & KRErrt.ER, H. (1976)
Cognitive orientation, type of smoker and behaviour
therapy of smoking, British Journal of Medical Pry-
chology, 49, pp. 167-175.
~ McKENNELt,, A. C. (1970) Smoking motivation fac-
tors, British Journal of Social and Clinical Psychology,
9, pp. 8-22.
~ N1AUR+, R, Go1.DsTm,r, M. G., WARD, K. D. &
, ABRAMS, D. B. (1989) Reasons for smoking and
severity of residual nicotine withdrawal symptoms
when using nicotine chewing gum, British Journal of
Addiction, 84, pp. 681-687.
~ PomFRLEAu, O. F. & PoMExr.Fr,u, C. S. (1984) Neu-
roregulators and the reinforcement of smoking:
towards a biobehavioral explanation, Neuroscience &
Biobehavioral Reviews, 8, pp. 503-513.
~ PoMERLEau, C. S., PoMERL.EAu, O. F., FtEsstarm,
K A. & BASSON, S. M. (1992) Relationship of
tridimensional personality questionnaire scores and
smoking variables in female and male smokers,
Journal of Substancu Abuse; 4, pp. 143-154.
~ RussEU., M. A. H., Psro, J. & PATEL, U. A. (1974)
i The classification of smoking by factorial structure
of motives, Journal of the Royal Statistical Sociay, A,
137, pp. 313-342.
~ ScHAcxTHx, S. (1978) Pharmacological and psycho-
logical determinants of smoking, Annals of Internal
Mtdiccine, 88, pp. 104-114.
SprEr.BERCEti, C. D., Gotzsucx, R. L & LustrnarE,
- R E. (1970) Manual for rlu State Trait Anxiay
_'. Invenrory (Palo Alto, CA, Counseling Psychologists
Press).
STANTON, W. R., MAxntAstct, P. A., McGES, R. &
Su.vA, P. A. (1993) Reasons for smoking or not
smoking in early adolescence, Addictive Behaviors,
18, pp. 321-329.
TATE, J. C., SCHMITZ, J. M. & STANTON, A. L. (1991)
A critical review of the reasons for smoking scale,
Journal of Substance Abuse, 3, pp: 441-455.
WEISSMAN, M. M., SHOt,oMAras, D., PorrENGER, M.,
PRUSxoFF, B. A. & LocKE, B. Z. (1977) Assessing
depressive symptoms in five psychiatric populations:
A validation study, American Journal of Epiderniology,
106, pp. 203-214.
WESr, R. J., HATEy,, P. & BEicHER, M. (1986) Which
smokers report most relief from craving when using
nicotine chewing gum, Psychopharmacology, 89, pp.
189-191.
WEST, R. J. & RussEit, M. A. H. (1985) Pre-absti-
nence smoke intake and smoking motivation as
predictors of severity of cigarette withdrawal symp-
toms, Psychopharmacology, 87, pp. 334-336.
APPENDIX I
Modified smoking motives questionnaire
ATM
1. I've found a cigarette in my mouth without re-
calling putting it there.
2. I light up a cigarette without realizing I still have
one burning in the ashtray.
3. I find myself smoking without remembering
lighting up.
SED
4. I smoke more when I am worried about some-
thing.
5. Smoking calms me down when I fell tense.
6. I light up a cigarette when I feel angry about
something.
SOC
7. It is easier to talk and get on with other people
when smoking.
8. Whi1e smoking I feel more confident with other
people.
9. I smoke much more when I am with other people.
IND
10. I want to smoke most when I am comfortable and
relaxed.
11. I like a cigarette best when I am having a quiet
rest.
12. I usually only smoke when I can really sit back and
enjoy it.
ADD
13. When I have run out of cigarettes I find it almost
unbearable until I can get them.
14. Without a cigarette I don't know what to do with
my hands.
15. I get a real gnawing hunger to smoke when I
haven't smoked for a while.
I

I
I
330 ,7ames C. Tate, Cynthia S. Pomerleau & Ovide F. Pomerleau
SMM STM
I 16. I smoke for the pleasure of having something to
put in my mouth.
17. Part of the enjoyment of smoking is watching the 19. I like smoking while .I am busy and working
hard.
20. I get a definite lift and feel more alert when
I smoke as I blow it out.
18. Part of the enjoyment of smoking comes from the
21. smoking.
I smoke more when I am rushed and have lots to
I
I
I
I
I
I
I
I
I
I
I
I
I
I steps I take to light up. do.
